ISRG

Intuitive Surgical
D

ISRG

Arincen88/100B

Intuitive Surgical income statement 1998–2026

11.58B USD over the last twelve months, and 10.06B USD in fiscal year 2025.

Revenue Operating income Net income

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Revenue
11.58B10.06B8.35B7.12B6.22B5.71B4.36B4.48B3.72B3.13B2.70B
Revenue growth
+20.45%+20.51%+17.24%+14.49%+8.97%+31.01%-2.68%+20.25%+19.03%+15.70%+13.42%
Cost of revenue
3.80B3.42B2.72B2.39B2.03B1.75B1.50B1.37B1.12B934.80M814.30M
Gross profit
7.78B6.64B5.63B4.73B4.20B3.96B2.86B3.11B2.60B2.19B1.89B
Gross margin
67.19%66.00%67.46%66.39%67.44%69.32%65.65%69.45%69.92%70.12%69.89%
Research and development
1.49B1.31B1.15B998.80M879.00M671.00M595.10M557.30M418.10M328.60M239.60M
Selling, general and administrative
3.00B2.39B2.14B1.96B1.74B1.47B1.22B1.18B986.60M810.90M705.30M
Operating expenses
4.50B3.70B3.29B2.96B2.62B2.14B1.81B1.74B1.40B1.14B944.90M
3.28B2.95B2.35B1.77B1.58B1.82B1.05B1.37B1.20B1.05B945.20M
Operating income growth
+16.62%+25.40%+32.95%+12.03%-13.39%+73.46%-23.62%+14.60%+13.73%+11.57%+27.73%
Operating margin
28.37%29.27%28.12%24.80%25.35%31.89%24.09%30.69%32.21%33.71%34.95%
Interest income
337.30M365.90M324.90M192.10M29.70M69.30M157.20M127.70M80.10M41.90M35.60M
Interest expense
———————————
Other non-operating income
334.90M365.90M324.90M192.10M29.70M69.30M157.20M127.70M80.10M41.90M35.60M
Pretax income
3.62B3.31B2.67B1.96B1.61B1.89B1.21B1.50B1.28B1.10B980.80M
Income tax
645.90M434.80M336.30M141.60M262.40M162.20M140.20M120.40M154.50M436.50M244.90M
Effective tax rate
17.85%13.13%12.58%7.23%16.33%8.58%11.62%8.01%12.08%39.81%24.97%
2.96B2.86B2.32B1.80B1.32B1.70B1.06B1.38B1.13B660.00M735.90M
Net income growth
+7.66%+22.97%+29.18%+35.98%-22.43%+60.72%-23.11%+22.29%+70.89%-10.31%+24.98%
Net margin
25.54%28.38%27.81%25.24%21.25%29.85%24.33%30.80%30.29%21.09%27.21%
Basic shares
353.33M356.90M355.20M351.20M355.70M356.10M351.00M346.20M341.10M335.10M344.70M
Diluted shares
357.58M362.70M362.00M357.40M362.00M365.80M360.90M358.50M356.40M348.90M353.70M
Change in diluted shares
-1.66%+0.19%+1.29%-1.27%-1.04%+1.36%+0.67%+0.59%+2.15%-1.36%+3.69%
EPS (basic)
8.378.006.545.123.724.793.023.983.311.972.13
EPS (diluted)
8.277.876.425.033.654.662.943.853.161.892.08
EPS growth
+9.39%+22.59%+27.63%+37.81%-21.67%+58.50%-23.64%+21.84%+67.20%-9.13%+20.23%
EBITDA
4.19B3.99B3.14B2.41B1.97B2.20B1.33B1.58B1.32B1.16B1.04B
EBITDA margin
36.20%39.63%37.55%33.88%31.70%38.54%30.42%35.22%35.50%37.14%38.52%
EBIT
3.54B3.31B2.67B1.96B1.61B1.89B1.05B1.37B1.20B1.06B949.70M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Figures underlined with dots are from the company's SEC filings, where our data provider's differ.

Common questions about Intuitive Surgical's income statement

Source: Financial Modeling PrepVerified against SEC filings